Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114880) titled 'Real-world study of senaparib capsule as first-line maintenance treatment in patients with newly diagnosed advanced ovarian cancer, primary peritoneal cancer,or fallopian tube cancer' on Dec. 18, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Henan Provincial People's Hospita,medical
Condition:
advanced ovarian cancer, primary peritoneal cancer, or fallopian tube cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Senapalli Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/...